ARHGAP5-AS1

Across TCGA pan-cancer cohorts, ARHGAP5-AS1 RNA is linked to patient survival in 24 of 34 cancer types, making it the most broadly survival-associated ARHGAP5-AS1 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher ARHGAP5-AS1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated ARHGAP5-AS1 expression acts as an unfavorable survival marker, although some lineages such as MESO and LGG show a favorable association.

BLCA, MESO, and LIHC are the cancer types where ARHGAP5-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Median	All	0.319	0.550	<.001	138	view →
MESO	OS	Quartile	II,III,IV	0.701	0.357	<.001	55	view →
LIHC	DFS	Median	All	0.446	0.628	<.001	54	view →
LGG	DFS	Quartile	All	0.758	0.583	<.001	39	view →
KIRC	OS	Median	All	0.704	0.562	<.001	37	view →
SKCM	OS	Quartile	II,III,IV	0.505	0.219	.003	32	view →
COAD	DFS	Tertile	All	0.725	0.823	.012	26	view →
LAML	DFS	Quartile	All	0.691	0.348	.009	24	view →
THCA	DFS	Median	All	0.898	0.761	<.001	19	view →
DLBC	DFS	Quartile	All	0.468	0.928	.007	14	view →
ACC	DFS	Tertile	All	0.387	0.735	.020	13	view →
LUAD	OS	Tertile	All	0.774	0.897	.003	13	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 24 lineages.

ARHGAP5-AS1–BLCA (OS)

Open the BLCA breakdown →